Plexus Corp. (NASDAQ:PLXS) CEO Sells $616,851.51 in Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey sold 4,337 shares of the stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $142.23, for a total transaction of $616,851.51. Following the transaction, the chief executive officer now directly owns 80,595 shares of the company’s stock, valued at $11,463,026.85. This represents a 5.11 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Plexus Stock Performance

NASDAQ:PLXS opened at $141.13 on Friday. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $3.82 billion, a price-to-earnings ratio of 32.74 and a beta of 0.89. The firm’s fifty day simple moving average is $159.02 and its 200 day simple moving average is $143.55. Plexus Corp. has a twelve month low of $90.18 and a twelve month high of $172.89.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a net margin of 3.03% and a return on equity of 10.36%. As a group, equities research analysts expect that Plexus Corp. will post 5.97 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Plexus

Several hedge funds and other institutional investors have recently made changes to their positions in PLXS. Quarry LP increased its stake in Plexus by 573.5% during the 3rd quarter. Quarry LP now owns 229 shares of the technology company’s stock worth $31,000 after buying an additional 195 shares during the period. R Squared Ltd purchased a new stake in Plexus during the 4th quarter worth $45,000. Point72 DIFC Ltd purchased a new stake in Plexus during the 3rd quarter worth $51,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Plexus during the 3rd quarter worth $55,000. Finally, USA Financial Formulas purchased a new stake in Plexus during the 4th quarter worth $56,000. Institutional investors and hedge funds own 94.45% of the company’s stock.

Analyst Ratings Changes

PLXS has been the subject of several analyst reports. Stifel Nicolaus initiated coverage on shares of Plexus in a report on Tuesday. They set a “hold” rating and a $152.00 price target for the company. Needham & Company LLC increased their target price on shares of Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a report on Friday, January 24th. StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a report on Monday, November 18th. Benchmark reaffirmed a “buy” rating and issued a $165.00 target price on shares of Plexus in a report on Wednesday, January 22nd. Finally, KeyCorp began coverage on shares of Plexus in a report on Tuesday, October 22nd. They issued a “sector weight” rating for the company. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $163.00.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.